title: Academic highlights: guidelines for the use of long-acting injectable atypical antipsychotics.
authors.forename: Samuel J
authors.initials: SJ
authors.lastname: Keith
authors.forename: John M
authors.initials: JM
authors.lastname: Kane
authors.forename: Martin
authors.initials: M
authors.lastname: Turner
authors.forename: Robert R
authors.initials: RR
authors.lastname: Conley
authors.forename: Henry A
authors.initials: HA
authors.lastname: Nasrallah
mesh_terms: D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use*; D003692:Delayed-Action Preparations; D006801:Humans; D007275:Injections, Intravenous; D008991:Monitoring, Physiologic; D010349:Patient Compliance; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D018967:Risperidone / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy*
chemical_list: D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations; D018967:Risperidone